These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26146552)
1. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes. Wang Y; Li J; Chen Y; Oupický D Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552 [TBL] [Abstract][Full Text] [Related]
2. Polymeric Plerixafor: effect of PEGylation on CXCR4 antagonism, cancer cell invasion, and DNA transfection. Wang Y; Li J; Oupický D Pharm Res; 2014 Dec; 31(12):3538-48. PubMed ID: 24942536 [TBL] [Abstract][Full Text] [Related]
3. Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor. Li J; Oupický D Biomaterials; 2014 Jul; 35(21):5572-9. PubMed ID: 24726746 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer. Tang S; Hang Y; Ding L; Tang W; Yu A; Zhang C; Sil D; Xie Y; Oupický D Mol Pharm; 2021 Dec; 18(12):4448-4458. PubMed ID: 34699242 [TBL] [Abstract][Full Text] [Related]
5. Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion. Li J; Zhu Y; Hazeldine ST; Li C; Oupický D Angew Chem Int Ed Engl; 2012 Aug; 51(35):8740-3. PubMed ID: 22855422 [TBL] [Abstract][Full Text] [Related]
6. Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia. Wang Y; Xie Y; Williams J; Hang Y; Richter L; Becker M; Amador C; Oupický D; Hyde RK Cancer Gene Ther; 2020 Feb; 27(1-2):45-55. PubMed ID: 31028289 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes. Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists. Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy. Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799 [TBL] [Abstract][Full Text] [Related]
10. The modification of siRNA with 3' cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes. Ambardekar VV; Han HY; Varney ML; Vinogradov SV; Singh RK; Vetro JA Biomaterials; 2011 Feb; 32(5):1404-11. PubMed ID: 21047680 [TBL] [Abstract][Full Text] [Related]
11. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Benoit DS; Henry SM; Shubin AD; Hoffman AS; Stayton PS Mol Pharm; 2010 Apr; 7(2):442-55. PubMed ID: 20073508 [TBL] [Abstract][Full Text] [Related]
12. Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer. Hang Y; Tang S; Tang W; Větvička D; Zhang C; Xie Y; Yu F; Yu A; Sil D; Li J; Singh RK; Oupický D J Control Release; 2021 May; 333():139-150. PubMed ID: 33774121 [TBL] [Abstract][Full Text] [Related]
13. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells. Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325 [TBL] [Abstract][Full Text] [Related]
14. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing. Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624 [TBL] [Abstract][Full Text] [Related]
15. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform. Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy. Kim J; Kang Y; Tzeng SY; Green JJ Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740 [TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme. Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134 [TBL] [Abstract][Full Text] [Related]
18. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration. Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972 [TBL] [Abstract][Full Text] [Related]
19. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. Xue J; Li R; Gao D; Chen F; Xie H Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392 [TBL] [Abstract][Full Text] [Related]
20. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]